P

Inventor

MEHTA KETAN

US33 patents
⚠️ This page may combine multiple inventors who share the name “MEHTA KETAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TRIS PHARMA INC

22 patents
US9198864B2Dec 1, 2015

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC55 citations99
US8883217B2Nov 11, 2014

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC57 citations99
US8790700B2Jul 29, 2014

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC70 citations99
US8747902B2Jun 10, 2014

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC70 citations99
US8597684B2Dec 3, 2013

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC77 citations99
US8491935B2Jul 23, 2013

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC95 citations99
US10933143B2Mar 2, 2021

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC36 citations98
US10668163B2Jun 2, 2020

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC36 citations98
US10172958B2Jan 8, 2019

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC37 citations98
US10086087B2Oct 2, 2018

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC36 citations98
US9675703B2Jun 13, 2017

Modified release formulations containing drug - ion exchange resin complexes

TRIS PHARMA INC49 citations98
US9675704B2Jun 13, 2017

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC49 citations98
US9549989B2Jan 24, 2017

Modified release formulations containing drug-ion exchange resin complexes

TRIS PHARMA INC40 citations98
US9522191B2Dec 20, 2016

Modified release formulations containing drug—ion exchange resin complexes

TRIS PHARMA INC40 citations98
US9040083B2May 26, 2015

Orally effective methylphenidate extended release powder and aqueous suspension product

TRIS PHARMA INC51 citations98
US8956649B2Feb 17, 2015

Orally effective methylphenidate extended release powder and aqueous suspension product

TRIS PHARMA INC51 citations98
US8778390B2Jul 15, 2014

Orally effective methylphenidate extended release powder and aqueous suspension product

TRIS PHARMA INC62 citations98
US8563033B1Oct 22, 2013

Orally effective methylphenidate extended release powder and aqueous suspension product

TRIS PHARMA INC67 citations98
US12076441B2Sep 3, 2024

Extended release amphetamine tablets

TRIS PHARMA INC0 citations62
US11590081B1Feb 28, 2023

Extended release amphetamine tablets

TRIS PHARMA INC1 citations62
US11590228B1Feb 28, 2023

Extended release amphetamine compositions

TRIS PHARMA INC1 citations62
US12458592B1Nov 4, 2025

Extended release amphetamine tablets

TRIS PHARMA INC0 citations45

MEHTA KETAN

9 patents

UNIV AKRON

1 patent

NEOTECH PRODUCTS LLC

1 patent